Abrupt cessation without medical guidance may result in suboptimal glycaemic control and potential complications related to unmanaged type 2 diabetes
Results are based on self-reported data from ~300,000 Remedy Meds members on personalized treatment plans, including compounded GLP-1 medications and clinician consultations
(2018) considerably influenced the pooled effect size, with its removal altering the effect size to 2.73 (95% CI: 1.737.20
See how our medically supervised program provides a safety net for your transformation, ensuring that medication remains a sustainable tool for long-term metabolic health
Our providers also offer alternatives, such as tirzepatide, for patients who are not good matches for semaglutide
Clinical trials and real-world studies have consistently demonstrated the efficacy of semaglutide in improving glycemic control and facilitating significant weight loss